Pharmafile Logo
Pharmafocus logo
Advanced Search
device_magnetic

Magnetic implant could revolutionise drug delivery

February 15, 2017
Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant

Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …

News
614px-flexed_plastic_display

Plastic electronics to bring “mind-blowing” developments for pharma

February 14, 2017
Manufacturing and Production, Research and Development plastic electronics

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …

News
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …

News
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …

News
marathon_logo

Marathon’s major misstep shows that drug pricing debate is here to stay

February 14, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon

Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …

News
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017
Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …

News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …

Feature

NICE turns down AZ’s chronic obstructive pulmonary disease drug

February 13, 2017
Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …

News
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …

News
ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017
Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …

News
iphone

First-ever approved fertility app more effective than the pill, experts say

February 13, 2017
Research and Development, Sales and Marketing contraception

Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …

News
seattle_genetics

Seattle Genetics’ prospective $2 billion licensing deal not without controversy

February 13, 2017
Sales and Marketing Immunomedics, Seattle Genetics, enVio

Immunomedics announced on 10 February that it had entered a licensing agreement with Seattle Genetics for its leading experimental cancer …

News
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …

Appointment
thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …

Appointment
intelligent_fingerprinting

Intelligent Fingerprinting secures £3 million funding for portable drug screening

February 10, 2017
Medical Communications, Research and Development Intelligent Fingerprinting, drug testing, nanotechnology

Intelligent Fingerprinting has received a funding boost to market its fingerprint-based drug screening system further. It is the world’s first …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Two of our top five stories this month are about one company in particular – a company that’s having a …

News

Vital Signs: Partnerships between industry, providers and academia

February 10, 2017
Medical Communications Deloitte

Hanno Ronte, life sciences partner at Deloitte, writes upon the opportunities available when a collaborative environment between industry, providers and …

News
brexit

Brexit could delay key drugs to UK patients, ex-MHRA chairman claims

February 10, 2017
Medical Communications, Sales and Marketing Cancer, MHRA, brexit

Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …

News
fda2outsideweb

FDA approves first treatment for Duchenne muscular dystrophy

February 10, 2017
Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, FDA, marathon, marathon pharmaceuticals

The FDA has announced that it has approved Emflaza (deflazacort), developed by Marathon Pharmaceuticals. The treatment will arrive on the …

News
mother-board-581597_960_720

Three quarters of healthcare companies to invest in big data by 2021

February 9, 2017
Medical Communications, Research and Development Big Data, analytics, clinical trials

The latest research by GBI Research suggests that there may be shift towards the use of big data and analytics …

News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026